Document is current
Any future updates will be listed below
-
Authors
Wirth, Wolfgang https://orcid.org/0000-0002-2297-8283
Maschek, Susanne
Wisser, Anna
Eder, Jana
Baumgartner, Christian F.
Chaudhari, Akshay
Berenbaum, Francis
Eckstein, Felix
,
-
Funding
Funding for this research was provided by:
Eurostars (E! 114932)
National Institutes of Health (N01AR22258, N01AR22259, N01AR22260, N01AR22261, N01AR22262)
Bundesministerium für Bildung und Forschung (01EC1408D)
Paracelsus Medical University
- License Information
-
More Information
Article History
Received: 3 July 2024
Revised: 26 August 2024
Accepted: 27 August 2024
First Online: 4 September 2024
Declarations
:
: Wolfgang Wirth and Susanne Maschek: employees and shareholders of Chondrometrics GmbH, a company that provides image analysis services and that received funding from multiple sources, including public bodies and the pharmaceutical industry (detailed list upon request). Anna Wisser: Employee of Chondrometrics GmbH. Jana Eder: employee of Siemens AG Österreich. Christian Baumgartner: none. Akshay Chaudhari: shareholder of Subtle Medical, Brain Key, and LVIS Corp; received personal fees from Subtle Medical and Patient Square Capital. Francis Berenbaum: consulting or speaker fees from 4P Pharma, Grunenthal, GSK, Eli Lilly, Heel, AstraZeneca, Diffusion Rx, Nordic Bioscience, Novartis, Pfizer, Servier, Zoetis. Shareholder of 4Moving Biotech. Felix Eckstein: CEO and shareholder of Chondrometrics GmbH. He provided consulting services to Merck KGA, Kolon Tissuegene (KTG), Galapagos, Novartis, 4P Pharma, and Formation Bio.
